LPL Financial’s Telomir Pharmaceuticals TELO Stock Holding History

LPL Financial’s Portfolio TELO Stock Details TELO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,000	Closed	-$64.2K	–	5457
2024 Q3	$64.2K	Buy	+10,000	New	+$48.7K	﹤0.01%	4964

Other funds holding TELO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

SEM

Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

LPL Financial's TELO Position: Q4 2024 in Review

LPL Financial sold out of Telomir Pharmaceuticals (TELO) in Q4 2024, closing a stake of 10,000 shares — an estimated $64.2K sold.

LPL Financial first reported a position in TELO in Q3 2024 and held it in 1 quarter. The position peaked at $64.2K in Q3 2024. 39 funds tracked by Wall St. Rank hold TELO as of Q4 2024.

LPL Financial reported no remaining Telomir Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
LPL Financial sold 10,000 Telomir Pharmaceuticals shares in Q4 2024, an estimated $64.2K.
LPL Financial first reported a position in Telomir Pharmaceuticals in Q3 2024 and held it in 1 quarter.
LPL Financial's Telomir Pharmaceuticals position peaked at $64.2K in Q3 2024.
39 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q4 2024.

Based on LPL Financial's 13F filing for Q4 2024, filed 11 Feb 2025.